Clinical Trials Browser

Phase 2/3 × Immunotherapy × Gastrointestinal × Clear all

NCT07000253 2025-06-02

OMEC-5

Phase 2/3 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT06907602 2025-04-02

ONTRESCC

Phase 2/3 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05955157 2024-01-10

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

Phase 2/3 Unknown

GastrointestinalOther solid neoplasm

Pancreatic Ductal Adenocarcinoma